Updated:
Quan Capital
Quan Capital is a life sciences venture firm with global vision and capabilities combined with unique China strengths. It invests in innovative early and...
Quan Capital
Quan Capital is a life sciences venture firm with global vision and capabilities combined with unique China strengths. It invests in innovative early and growth stage life sciences companies, with primary focus on therapeutics and related areas including enabling technologies and high-end services, etc. The Quan team is led by seasoned investment professionals with strong track record of consistently high returns. They are highly successful company builders with deep industry knowledge across biopharma value chain. With presence in both China and US, Quan leverages its expertise in cross-border value creation with strong local execution capabilities.
General information
Firm type
Private Equity
Year founded
2017
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Grand Cayman
Corporate office
899 Halei Road, Building B, 4/F, Pudong New Area, Shanghai 201203, P.R. China
Additional offices
Las Vegas, Nevada, United States
Principals
Founding Managing Director
Founding Managing Director
Managing Director
Managing Director
Venture Partner
Venture Partner
Senior Advisor
Senior Advisor
Partner
Partner
Vice President
Vice President
Senior Associate
Senior Associate
Director, Finance
Director, Finance
Senior Accountant
Senior Accountant
Operation Manager
Operation Manager
Executive Assistant
Executive Assistant
Sector focus
Frequently asked questions
What stages does Quan Capital target in its investments?
Quan Capital invests in early and growth-stage life sciences companies. Its strategy is agnostic to specific round labels but focuses on innovative biotech, pharma, enabling technologies, and precision medicine businesses that require scientific and operational company-building support.
In which geographies does Quan Capital primarily invest?
Quan Capital makes global investments with a particular emphasis on connecting portfolio companies to the China and United States markets. It maintains offices in Shanghai and Las Vegas to support cross-border operations for its portfolio.
How does Quan Capital differentiate its approach from other life sciences venture investors?
The firm describes itself as a company builder rather than a passive capital provider. Quan Capital’s investment professionals directly support strategy, operations, and development within portfolio companies, and draw on an extensive network across the science and business communities globally and in China.
Does Quan Capital invest in sectors outside of therapeutics?
Yes. While therapeutic biotech and pharma are core areas, Quan Capital also invests in enabling technologies, high-end specialty services, and companion diagnostics that fall under the precision medicine umbrella.
Who leads Quan Capital’s investment decisions?
Quan Capital’s investment decisions are managed by a team that includes a Founding Managing Director, a Managing Director, a Venture Partner, and other senior investment professionals. Specific named individuals beyond titles are not publicly listed on the firm’s website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: